Gilead wins European approval for HIV prevention injection

Go back to Gilead wins European approval for HIV prevention injection
Gilead Sciences (NASDAQ: GILD) Delayed: 143.44 -4.16 (2.82%)
Previous Close $147.60    52 Week High $108.63 
Open $146.69    52 Week Low $71.39 
Day High $146.82    P/E 79.25 
Day Low $143.19    EPS $1.81 
Volume 7,160,206